NASDAQ · Biotechnology

QTTB (QTTB) Stock

$15.56 +6.28% NASDAQ: QTTB Healthcare

Valuation

MetricValue
Price$15.56
Market Cap$198.80M
P/E Ratio2.34
P/B Ratio1.72
P/S Ratio1.35
EPS (TTM)$2.42
52-Week High$22.54
52-Week Low$1.34
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE71.43%
ROA48.39%
ROCE40.48%
Gross Margin31.48%
Operating Margin31.48%
Net Margin61.86%
Debt/Equity0.24
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$7.0M$-7.0M$0$54.0M
Operating Profit$-96.0M$-39.0M$-48.0M$-66.0M$17.0M
Net Profit$-96.0M$-43.0M$-54.0M$-48.0M$30.0M
EPS$-31.18$-13.42$-16.70$-6.58$2.42
Op Margin-282.4%-589.8%725.5%—31.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$212.0M$62.0M$47.0M$92.0M$62.0M
Total Liabilities$42.0M$192.0M$230.0M$87.0M$20.0M
Cash$108.0M$44.0M$26.0M$78.0M$48.0M
Borrowings$24.0M$45.0M$51.0M$19.0M$15.0M

Latest News

Wall Street Analysts See an 80.12% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? Zacks · Jul 15, 2026 Q32 Bio Prices $200 Million Offering of Stock, Pre-funded Warrants MT Newswires · Jul 15, 2026 Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PR Newswire · Jul 15, 2026 Q32 Bio stock surges 83% on positive alopecia drug trial data Quartz · Jul 14, 2026 Q32 Bio (QTTB) After Positive Trial Data Is It A Buy Or Already Fairly Valued Simply Wall St. · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-110.0M$-11.0M$-19.0M$-68.0M$-34.0M
Investing Cash Flow$-53.0M$-5.0M$0$20.0M$7.0M
Financing Cash Flow$0$0$0$46.0M$0
Net Cash Flow$-109.0M$17.0M$-8.0M$47.0M$-30.0M
Free Cash Flow$-112.0M$-13.0M$-19.0M$-68.0M$-34.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA2.32
FCF Yield-37.83%
Quick Ratio5.36
Interest Coverage17.00
Return 1Y654.81%
Return 3Y-8.19%
Return 5Y-86.41%

Ownership

Insiders Held4.24%
Institutions Held130.63%
Institutions Float Held136.43%
Institutional HolderSharesReport Date
Orbimed Advisors LLC.2,252,9872026-03-31
Atlas Venture Life Science Advisors, LLC 2,092,1062026-03-31
Opaleye Management Inc.1,256,2282026-03-31
Carlyle Group Inc.1,102,7412026-03-31
Arch Venture Management, Llc320,4822026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTX $4.93 +0.20% -4.76 $177.56M 0.00%
BOLD $2.48 -3.50% -0.56 $55.74M 0.00%
GBIOGeneration Bio Co. $5.34 +0.00% -0.87 $35.98M 0.00%
INTS $4.57 +2.70% -0.60 $12.35M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About QTTB

QTTB is led by CEO Jodie Pope Morrison, employs 28 people, headquartered in US, publicly traded since 2018.

QTTB stock trades at $15.56 with a market capitalization of $198.80M. The stock is valued at a price-to-earnings (P/E) ratio of 2.34, price-to-book of 1.72, price-to-sales of 1.35. Over the past 52 weeks the stock has ranged between $1.34 and $22.54, and currently trades 31.0% below its 52-week high.

On profitability, QTTB generates a return on equity (ROE) of 71.43% — well above the market average, a sign of a high-quality business, return on capital employed of 40.48%, an operating margin of 31.48%, a net profit margin of 61.86%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides